Docetaxel (Accord Healthcare Inc.)


Welcome to the PulseAid listing for the Docetaxel drug offered from Accord Healthcare Inc.. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Accord Healthcare Inc.
NON-PROPRIETARY NAME: Docetaxel
SUBSTANCE NAME: DOCETAXEL ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Microtubule Inhibition [PE],Microtubule Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-07-01
END MARKETING DATE: 0000-00-00


Docetaxel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDocetaxel from Accord Healthcare Inc.
LABELER NAME: Accord Healthcare Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/mL)
START MARKETING DATE: 2012-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 16729-231_4b7f22ab-2e31-0695-e054-00144ff88e88
PRODUCT NDC: 16729-231
APPLICATION NUMBER: NDA201195

Other DOCETAXEL ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Docetaxel
Hospira, Inc.Docetaxel
Ingenus Pharmaceuticals, LLCDOCETAXEL
McKesson Packaging Services a business unit of McKesson CorporationDocetaxel
Northstar RxLLCDocetaxel
Sagent PharmaceuticalsDocetaxel
Teva Parenteral Medicines, Inc.Docetaxel